# Circulating Cancer Cells/Macrophage HYbrid Cells in Patients With Breast Cancer.

> **NCT04818125** · NA · COMPLETED · sponsor: **Institut Claudius Regaud** · enrollment: 61 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **OTHER:** Patients with breast cancer (stage I, II III or IV)

## Key facts

- **NCT ID:** NCT04818125
- **Lead sponsor:** Institut Claudius Regaud
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-03-31
- **Primary completion:** 2022-07-29
- **Final completion:** 2022-07-29
- **Target enrollment:** 61 (ACTUAL)
- **Last updated:** 2022-09-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04818125

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04818125, "Circulating Cancer Cells/Macrophage HYbrid Cells in Patients With Breast Cancer.". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04818125. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*